05-Aug-2021 - Tecan Group Ltd

Tecan successfully completes the acquisition of Paramit

The Tecan Group  announced that it has successfully completed the acquisition of US-based Paramit Corporation and its affiliates (“Paramit”) for a total purchase consideration of USD 1.0 billion (CHF 920 million). On June 23, 2021, Tecan entered into a definitive agreement to acquire Paramit.

Paramit, headquartered in Morgan Hill (CA), US, is a leading OEM developer and manufacturer of medical devices and life sciences instruments. With the addition of approximately USD 300 million in revenues (CHF 276 million) expected in 2022, the acquisition will further extend Tecan’s position in solutions for life sciences and in-vitro diagnostics (IVD). It will also add a new business vertical in the attractive and fast-growing market for medical devices. The acquisition will bring significant engineering as well as cost-competitive manufacturing capabilities, both in North America and in the APAC region. Equipped with proprietary computer-directed assembly technology, these facilities deliver ultra-flexible production planning, while reducing the potential for errors (“zero-defect manufacturing”).

From August 1, 2021, Paramit will be included in the consolidated financial statements of the Tecan Group as a part of the Partnering Business segment.

Facts, background information, dossiers
More about Tecan
  • News

    Tecan strengthens development and operations organizations

    The Tecan Group announced that the Company will strengthen its global Development and Operations organizations. To continue to drive Tecan’s leading innovation capabilities, Dr. Wael Yared has been appointed as CTO and Head Research & Development and a member of the Management Board of the ... more

    Achim von Leoprechting promoted to become CEO of Tecan after retirement of David Martyr

    The Tecan Group announced the retirement of Tecan CEO Dr David Martyr after 6 1/2 years at the helm of the company. The Board of Directors has appointed Dr Achim von Leoprechting, Head of Tecan's Partnering Business division, as the new Chief Executive Officer. He will assume the CEO role o ... more

    Tecan appoints Klaus Lun Head of the Life Sciences Business division

    The Tecan Group announced that Dr. Klaus Lun, Head of Corporate Development and a member of the Management Board of the Tecan Group since June 2013, has been appointed Head of the Life Sciences Business division. On December 14, 2016, Tecan announced that Dr. Stefan Traeger, Head of the Lif ... more

  • Companies

    Tecan Schweiz AG

    Tecan is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics. The company specializes in the development, production and distribution of automation solutions for laboratories in the life sciences sector. With its subsi ... more

    Tecan Deutschland GmbH

    Tecan is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its cl ... more

    Tecan Austria GmbH

    Tecan is a leading global provider of automated laboratory instruments and solutions. Our systems and components help people working in clinical diagnostics, basic and translational research and drug discovery bring their science to life. In particular, we develop, produce, market and supp ... more